Tuberous sclerosis (TS) is an accepted autosomal dominant trait with characteristic dermatological and neurological features (table 1) . Mental handicap occurs in more than half of recognised affected subjects.1 The variable expression seen in TS can often complicate initial diagnosis; this, however, is facilitated by adherence to diagnostic criteria as described by Gomez.2 In recent years the recognition of more diagnostic signs together with more complete evaluation of family members has led to increasing estimates of the prevalence of TS. J R Sampson, S J Scahill, J B P Stephenson, L Mann, and J M Connor studied subpopulations of institutionalised patients12 13 or based their estimates on very small numbers of cases.14 15 The recognition of further diagnostic signs and formulation of diagnostic criteria2 has enabled better ascertainment in recent studies.1 16 Estimates of the prevalence of TS will inevitably be underestimates beause of the occurrence of minimally affected cases who may not come to medical attention. We often ascertained mildly affected subjects through more severely affected descendants. As in previous studies a much higher prevalence was found among children (1 in 12 000 under 10 years) than among adults. This reflects in part the increased mortality associated with the condition and possibly increasing diagnostic awareness among paediatricians.
Because most large studies have not attempted thorough assessment of the parents of apparently sporadic cases, the proportion of new mutations is likely to have generally been overestimated. Although we attempted to examine the parents of index cases wherever this was possible, they were only rigorously investigated (brain CT scan, renal USS, skeletal survey) where further children were being considered, doubtful signs of TS were found, or if they were taking part in linkage studies. The proportion of sporadic cases among those whose parents were clinically evaluated is compared with previous reports in table 2. The lack of a significant parental age effect for new mutations is in keeping with the findings of previous studies which have addressed this question.8 11 17 The mutation rate for the TS §ene has most recently been estimated at 2-5 x 10-per gene per generation.' We derived the same figure from our data, which gave a higher prevalence but a lower proportion offresh mutations. This mutation rate would suggest 18 new cases of TS per year to normal parents in the UK.
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